Surrozen, Inc. Common

SRZNNASDAQUSD
21.78 USD
0.43 (1.94%)AT CLOSE (11:59 AM EDT)
21.78
0.01 (0.02%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
21.78
0.01 (0.02%)
🔴Market: CLOSED

SRZN is currently priced at $21.82. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (129.6%) and a bullish Golden Cross on the moving averages. On the valuation front, SRZN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Aug 3, 2026.

Open?$22.45
High?$23.12
Low?$21.36
Prev. Close?$22.21
Volume?230.4K
Avg. Volume?233.1K
VWAP?$21.95
Rel. Volume?0.99x
Bid / Ask
Bid?$13.90 × 100
Ask?$39.98 × 100
Spread?$26.08
Midpoint?$26.94
Valuation & Ratios
Market Cap?257.9M
Shares Out?11.6M
Float?4.1M
Float %?47.9%
P/E Ratio?N/A
P/B Ratio?-0.93
EPS?-$31.05
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Employees
44
Market Cap
257.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-08-12
Address
171 OYSTER POINT BLVD
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-475-2820
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
50
Short Sent.?
15
Piotroski F-Score?2/9Weak
Altman Z-Score?-7.28Distress
Confidence?63%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?23.65%Squeeze Risk
Short Interest?971.0K
Days to Cover?6.2
Free Float4.1M
Avg Daily Volume155.8K
Settlement Date2026-07-15
Financial Health
Current Ratio?11.91Strong
Quick Ratio?11.91Strong
Cash Ratio?11.18Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
S&P
97
-0.93CHEAP
P/S?
Peers
100
S&P
3
34.41HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-3.5CHEAP
EV/Sales?
Peers
100
S&P
3
20.14HIGH
Returns & Efficiency
ROE?
Peers
50
S&P
97
129.6%STRONG
ROA?
S&P
3
-298.7%WEAK
Cash Flow & Enterprise
FCF?$-33681000
Enterprise Value?$151.0M
Fundamentals ratios updated end of day